Bronchiectasis is one of the most neglected chronic lung diseases despite the fact it impacts 300,000 people in the UK ...

Interstitial lung abnormalities (ILAs) are parenchymal lung changes found on high-resolution CT. In routine use of high-resolution CT, non-specific findings are frequently reported, which has prompted ...

Cleveland Clinic Abu Dhabi has made history by performing the Gulf region’s first-ever robotic lung transplant, making it one ...

The New Jersey-based pharma has inked one of the biggest deals of the year in pursuit of a promising new way to treat COPD.

Anne Dockery, from Southville, Bristol, took up running at the age of 52 and began competing in triathlons in her 60s. Her ...

Many children continue to experience respiratory symptoms up to 14 years after treatment for protracted bacterial bronchitis, ...

The deal gives Merck access to Verona Pharma’s new chronic obstructive pulmonary disease medication Ohtuvayre.

Verona Pharma brings to Merck the inhaled drug Ohtuvayre, which is FDA approved as a treatment for chronic obstructive pulmonary disease. While Ohtuvayre is projected to become a blockbuster product ...

Synchrony Medical announced that it received FDA 510 (k) clearance for its LibAirty airway clearance system.